Aerovate Therapeutics (NASDAQ:JBIO) Upgraded by Wall Street Zen to “Hold” Rating
Wall Street Zen upgraded shares of Aerovate Therapeutics (NASDAQ:JBIO – Free Report) to a hold rating in a research report report published on Saturday morning. Aerovate Therapeutics Stock Down 2.6% Shares of NASDAQ:JBIO opened at $6.76 on Friday. The company has a market capitalization of $5.69 million, a P/E ratio of -0.11 and a beta […]
Wall Street Zen upgraded shares of Aerovate Therapeutics (NASDAQ:JBIO – Free Report) to a hold rating in a research report report published on Saturday morning. Aerovate Therapeutics Stock Down 2.6% Shares of NASDAQ:JBIO opened at $6.76 on Friday. The company has a market capitalization of $5.69 million, a P/E ratio of -0.11 and a beta […]
